support@Everyonestore.com +1(442)-900-4951
Xphozah (Tenapanor)
$1,556.55
Xphozah (tenapanor) is a prescription medicine for the treatment of adult patients with chronic kidney disease (CKD) 1.
Xphpzah (tenapanor) is approved by the FDA in the USA 2.
What is Xphozah (tenapanor) for?
Xphozah (tenapanor) is the first and only phosphate absorption inhibitor approved for the treatment of adult patients with chronic kidney disease (CKD). The medicine is indicated for patients who are on dialysis, or as an add-on therapy in patients who have not responded adequately to or are intolerant to phosphate binder therapy [1].
Xphozah (tenapanor) is available in the form of tablets ( 10 mg, 20 mg, and 30 mg) [1].
How does Xphozah (tenapanor) work?
Tenapanor is a medication that targets a specific protein called the sodium/hydrogen exchanger 3 (NHE3), found on the inside walls of the small intestine and colon. This protein normally helps the body absorb sodium from the food we eat.
When tenapanor blocks this protein, it causes the body to absorb less sodium. Additionally, because the way our body handles phosphate is tied to sodium, less phosphate is absorbed as well. In short, tenapanor reduces the amount of sodium and phosphate that our body takes in from the digestive tract [1].
Where has Xphozah (tenapanor) been approved?
Xphozah (tenapanor) is currently approved by the FDA in the USA [2].